Manmeet Singh Soni
Director of Finance/CFO bei SUMMIT THERAPEUTICS INC.
Vermögen: 11 Mio $ am 30.04.2024
Profil
Herr Manmeet Singh Soni, CPA, ist Executive VP, Chief Operating & Financial Officer bei Reata Pharmaceuticals, Inc. und ein unabhängiger Non-Executive Director bei Arena Pharmaceuticals, Inc. sowie ein unabhängiger Director bei Pulse Biosciences, Inc. und ein unabhängiger Director bei Summit Therapeutics, Inc. Er ist Mitglied des Board of Directors bei Summit Therapeutics Ltd., Arena Pharmaceuticals, Inc. und Pulse Biosciences, Inc. Herr Soni war zuvor als Senior VP, Chief Financial & Accounting Officer bei Alnylam Pharmaceuticals, Inc. tätig, als Chief Financial Officer & Treasurer bei ARIAD Pharmaceuticals, Inc. und als Chief Financial Officer & Treasurer bei Pharmacyclics, Inc. sowie als Controller & Senior Director-Finance bei ZELTIQ Aesthetics, Inc. und als Senior Manager-Life Science bei PricewaterhouseCoopers LLP. Außerdem war er Vorstandsmitglied bei Genoscience Pharma. Seinen Bachelor-Abschluss erhielt er am Hansraj College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SUMMIT THERAPEUTICS INC
0,42% | 02.04.2024 | 2 976 190 ( 0,42% ) | 11 Mio $ | 30.04.2024 |
PULSE BIOSCIENCES, INC.
-.--% | 12.04.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Manmeet Singh Soni
| Unternehmen | Position | Beginn |
|---|---|---|
| PULSE BIOSCIENCES, INC. | Director/Board Member | 02.11.2017 |
| SUMMIT THERAPEUTICS INC. | Director of Finance/CFO | 02.04.2024 |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Director/Board Member | 24.12.2019 |
Ehemalige bekannte Positionen von Manmeet Singh Soni
| Unternehmen | Position | Ende |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Director of Finance/CFO | 26.09.2023 |
| ARENA PHARMACEUTICALS | Director/Board Member | 11.06.2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Director of Finance/CFO | 12.08.2019 |
| ARIAD PHARMACEUTICALS, INC. | Director of Finance/CFO | 01.02.2017 |
Ausbildung von Manmeet Singh Soni
| Hansraj College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| PULSE BIOSCIENCES, INC. | Health Technology |
| SUMMIT THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
ZELTIQ Aesthetics, Inc.
 ZELTIQ Aesthetics, Inc. Medical SpecialtiesHealth Technology ZELTIQ Aesthetics, Inc. is a medical technology company, which focuses on developing and commercializing products. Its product, the coolsculpting system is designed to selectively reduce stubborn fat bulges. The company was founded by Mitchell E. Levinson in 2005 and is headquartered in North Chicago, IL. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
